Number of docs using smartphones surges

Share this article:

The number of physicians using smartphones in 2009 surged to 64%, according to the results of a new study by Manhattan Research. The study, Taking the Pulse v9.0, focused on physician adoption, use and impact of the Internet and other technologies. The group of physicians who use mobile devices such as iPhones and BlackBerries increased by 20% between 2008 and 2009, according to the study, and the number of physicians using iPhones alone more than doubled in the past year.

Survey results indicate that physicians' increased reliance on smartphones is not cannibalizing Internet usage on computers. Study data reveals that physicians are spending more time online overall and are using both computers and smartphones to access to the most up-to-date online medical and pharmaceutical resources at a variety of points throughout the day.

In addition, physicians who use smartphones are an important group to take note of for strategy planning, particulalry for brand teams looking to leverage the evolving physician media mix in building relationships with their target audiences, according to the study.

Monique Levy, senior director of research at Manhattan Research, said that while physicians have always been advanced in terms of their mobile use, now, the  growth in smartphone ownership in the last year has been remarkable. Levy said that mobile is delivering on its promise to allow doctors to be "always on" and acccounts for why so many doctors say the internet is essential to their practice.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...